Filing Summary
Genmab A/S furnished this Form 6-K as a foreign private issuer for October 2026, dated October 5, 2026. The filing identifies the company’s principal executive offices in Valby, Denmark. The provided text contains the Form 6-K cover and exhibit index, but not the referenced company announcement.
Financial and Operating Information
The provided filing text does not report revenue, profit, cash flow, margins, debt, liquidity, or other financial or operating metrics. It also provides no comparable-period data.
Outlook, Risks, and Other Items
No guidance, management commentary, risks, contingencies, or unusual items are described in the provided text. Exhibit 99.1 is listed as a company announcement dated October 5, 2026, but its contents are not included here.
The 6-K states that it is incorporated by reference into specified Genmab Form S-8 registration statements, to the extent not superseded by later filings or reports.
Key Facts to Verify
- Obtain and review Exhibit 99.1, which is not included in the provided filing text.
- Confirm whether the company announcement contains material financial, operating, or outlook information.